Victory Capital Management Inc Provention Bio, Inc. Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$6.7 - $24.21 $272,361 - $984,160	-40,651 Reduced 81.89%	8,989 $216,000
Q4 2022 Feb 09, 2023	BUY	$4.52 - $10.57 $224,372 - $524,694	49,640 New	49,640 $524,000
Q1 2021 May 04, 2021	SELL	$10.12 - $19.45 $948,648 - $1.82 Million	-93,740 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$11.79 - $18.94 $463,842 - $745,137	-39,342 Reduced 29.56%	93,740 $1.59 Million
Q3 2020 Nov 09, 2020	SELL	$10.34 - $15.2 $30,585 - $44,961	-2,958 Reduced 2.17%	133,082 $1.71 Million
Q2 2020 Aug 07, 2020	BUY	$7.81 - $17.0 $1.01 Million - $2.2 Million	129,603 Added 2013.41%	136,040 $1.92 Million
Q1 2020 May 04, 2020	SELL	$5.42 - $17.75 $1,246 - $4,082	-230 Reduced 3.45%	6,437 $59,000
Q4 2019 Feb 04, 2020	BUY	$5.84 - $14.9 $13,794 - $35,193	2,362 Added 54.87%	6,667 $100,000
Q3 2019 Nov 12, 2019	BUY	$6.83 - $13.0 $29,403 - $55,965	4,305 New	4,305 $29,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.